FolioLanternBeta
GHGuardant Health, Inc.

Medina Hidalgo

Director at Guardant Health, Inc., as of Sep 21, 2026Sold $936K of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
61%†
share of stake sold at Guardant Health, Inc.
† Measured against shares held at the start plus shares received, because most of the shares sold arrived during the period.
5K
shares held after the latest filing, Guardant Health, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
2
companies filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNov 2025: $143K no plan disclosedNovDec 2025: $131K no plan disclosedDecJanFebMar 2026: $119K no plan disclosedMarAprMay 2026: $264K no plan disclosedMayJunJulAug 2026: $279K no plan disclosed$279KAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Guardant Health, Inc. (GH)DirectorJul 19, 2024Sep 21, 2026
Bristol Myers Squibb (BMY)DirectorJun 3, 2021Feb 3, 2026

Also a director at

Bristol Myers Squibb (BMY)

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.